INTRODUCTION
Depression, bipolar disorder (BD) and epilepsy are common, chronic, episodic brain disorders 1-3 sharing many features, including very high social cost and elevated suicide risk. [4] [5] [6] Mood disorder is the most frequent major comorbidity associated with epilepsy, and the risk of exhibiting BD symptomatology in epilepsy patients has been estimated at 10-12%. 7 Conversely, patients with BD are reported to have an approximately twofold to fourfold increased risk of epilepsy. [8] [9] [10] Identification of Mendelian epilepsy genes has enabled studies of pathophysiological mechanisms and driven efforts toward mechanism-based epilepsy therapy. 11 Although BD is highly heritable, 12 its genetic and phenotypic complexity makes the task of identifying underlying biological mechanisms especially challenging even when association signals are known. 13 ANK3 is a leading candidate gene in BD, implicated by multiple genome-wide association and targeted replication studies in diverse populations. [14] [15] [16] [17] [18] [19] ANK3 uses alternative transcriptional start sites, alternative first exons and additional downstream alternative exons to produce multiple isoforms of its protein product, ankyrin-G (AnkG) (Figures 1a and b ). 20, 21 Alternative ANK3 first exons 1a/1a', 1e and 1b encode AnkG N-terminal peptide sequences, here called NT1, NT2 and NT3, respectively (Figures 1a, b and Supplementary Figure S1 ). In neurons, AnkG clusters voltage-gated sodium (Na V ) and KCNQ2/3 potassium channels at axonal initial segments (AISs) and nodes of Ranvier, enabling action potential (AP) generation and conduction. [22] [23] [24] The ANK3 1e and 1b alternative first exons encode highly conserved AnkG N-terminal peptides (Supplementary Figure S1 ) that control the ratio of neuronal Na V and KCNQ2/3 channels binding to AnkG and, hence, excitability. 25 Remarkably, six different neuronal Na V and KCNQ channels bound near the AnkG N-terminus are encoded by genes mutated in human Mendelian epilepsy syndromes (SCN1A, SCN2A, SCN8A, SCN1B, KCNQ2 and KCNQ3). 26 Drugs that block Na V channels (that is, carbamazepine, lamotrigine, valproic acid) or promote opening of KCNQ2/3 channels (valproic acid) 27 are used widely for both epilepsy and BD. 28 Thus converging human genetic, molecular and clinical pharmacological evidence makes ANK3 an appealing candidate for BD and mood disorder-epilepsy comorbidity.
We noted that many of the BD-associated ANK3 variants lie within candidate cis-regulatory regions between exons 1e and 1b ( Figure 1a ). 29, 30 Furthermore, recent experiments in human and mouse provide hints that decreased expression of ANK3 isoforms containing exon 1b may increase BD susceptibility, whereas decreased exon 1e expression may be protective. 21, 31 The rs1938526 single-nucleotide variant, associated with increased BD risk in several independent studies, has been shown to correlate with reduced human brain levels of exon 1b-containing mRNA. 21, 32 Mice heterozygous for exon 1b deletion have a behavioral phenotype characterized by reduced anxiety and increased motivation for reward at baseline, which transitions to depression-related features after repetitive stress, modeling decompensation in BD. 31 The rs41283526 single-nucleotide polymorphism, which lies downstream of exon 1e and causes impaired splicing and reduced mRNA expression, was found be protective both for BD (odds ratio, 0.31) and schizophrenia (odds ratio, 0.21) ( Figure 1a ). 32 However, neurophysiological mechanisms explaining why altered ANK3 exons 1b and 1e expression might influence susceptibility to BD and epilepsy are unknown.
We investigated the expression and function of AnkG isoform subfamilies defined by alternative first exons and alternative N-termini in mouse and human. We obtained robust molecular, electrophysiological and behavioral evidence that AnkG exon 1b expression controls the excitability of parvalbumin (PV)-expressing fast-spiking inhibitory neurons 33 that are known to control output gain in neocortical microcircuit responses. 34, 35 Our findings provide clear, conceptually simple links between AnkG expression, excessive output in neuronal circuits, epilepsy and emotional disorder.
MATERIALS AND METHODS Animals
C57BL/6J Ank3-exon 1b 20 and conditional Ank3 knockout (KO) 36 founder mice were provided by Vann Bennett. All mutant mice used in experiments were produced by crosses of animals heterozygous at all alleles in order to generate test mice and littermate controls. Mice expressing tdTomato in PV interneurons were generated as described. 37 Ank3-exon 1b mutant animals expressing tdTomato in PV interneurons were used for slice electrophysiology and electroencephalography; their genotypes are Ank3-1b +/+ -PVcre-tdTom, Ank3-1b KO/+ -PVcre-tdTom and Ank3-1b KO/KO -PVcre-tdTom (here called Ank3-1b +/+ -PVtom, Ank3-1b KO/+ -PVtom and Ank3-1b KO/KO -PVtom mice, respectively). This combination of alleles allowed for the constitutive Ank3 exon1b KO mice to express tdTomato fluorescence in only PV interneurons. Conditional Ank3 KO of AnkG in PV interneurons used mice with lox-P sites flanking Ank3 exons 22 and 23, which are constitutive in all large AnkG isoforms. 36 These mice were crossed with PV-cre;tdTom mice to generate PV-specific Ank3 KO mice expressing tdTomato (hereafter called Flox-Ank3 KO/KO ). Restricted tdTomato expression in PV interneurons was verified by comparing tdTomato fluorescence and PV immunofluorescence using confocal microscopy. Primers for genotyping Ank3-1b alleles 20 and Flox-Ank3 alleles 36 were reported previously. Primers used for genotyping PV-cre (The Jackson Laboratory, Bar Harbor, ME, USA; stock no. 008069) and tdTomato (The Jackson Laboratory, stock no. 007905) mice were those recommended by The Jackson Laboratory catalog. Mice used in immunostaining and electroencephalography (EEG) experiments were 6-8 weeks of age. Both sexes were used in all preliminary experiments and exhibited the same robust immunostaining pattern and EEG phenotypes. Subsequently, experiments quantifying staining intensity and EEG features were performed on male mice only. All animal procedures followed protocols approved by the IACUC committees of Baylor College of Medicine and the University of Wyoming.
Human tissues
Human brain samples were obtained under a protocol approved by the Baylor College of Medicine Institutional Review Board. Overlying neocortical tissue removed as part of routine care from patients undergoing surgery for epilepsy and tumors (ages 9-19 years) was used. Cortical tissue blocks (approximately 5 mm 3 ) were immersion fixed (4% paraformaldehyde, 2 h), located and oriented using surgical notes and the intact pial surface, embedded in OCT, cryosectioned (60 μm) and processed as described for mouse samples.
Materials
To generate an NT2-AnkG-GFP expression construct, we cloned Ank3-exon1e cDNA (GE Dharmacon, Lafayette, CO, USA, catalog no. MMM1013-64925) into pEGFP-N1. Vann Bennett provided a rat NT3-AnkG270-GFP plasmid and affinity-purified rabbit anti-PanAnkG antibodies (raised against a large C-terminus fusion protein). Isoform-specific rabbit antibodies against portions of the NT1-AnkG, NT2-AnkG and NT3-AnkG peptides were raised (YenZym, Inc., South San Francisco, CA, USA) and affinity-purified using methods described previously. 38 Antigenic peptides used were derived from the human sequences, with a C-terminal cysteine residue added for conjugation: NT1 (NT1-AnkG residues 8-29): SPAGTEDSAPAQGGFGSDYSRSSRKSC; NT2 (residues 2-21): SEEPKEKPAK-PAHRKRKGKKC; and NT3 (residues 2-21): AHAASQLKKNRDLEINAEEEC. Purchased primary antibodies were mouse N-terminal isoform nonselective mouse anti-AnkG, called here 'Pan AnkG' (IgG2a, clone N106/36; UC Davis/NIH NeuroMab Facility; Davis, CA, USA), mouse anti-PV (IgG1, clone Parv-19, Sigma-Aldrich; St Louis, MO, USA) and mouse anti-PanNa V (IgG1, Sigma-Aldrich). Corresponding secondary antibodies were DyLight488 donkey-anti-rabbit IgG (Jackson ImmunoResearch, West Grove, PA, USA), AlexaFluor647-conjugated goat anti-mouse IgG1 (Invitrogen, Eugene, OR, USA), AlexaFluor555-conjugated goat anti-mouse IgG2a (Invitrogen) and, for western blottings, horseradish peroxidaseconjugated anti-rabbit IgG (Jackson Laboratories).
Western blotting
Forebrain and cerebellum were dissected from three P6 mice, homogenized (100 mg wet weight ml − 1 ) in buffer containing 40 mM Tris-HCl (pH 7.4), 150 mM NaCl, 1% Triton X-100 (Tx-100), 1 × Complete protease inhibitor (Roche, Diagnostic, Indianapolis, IN, USA) and 1 mM dithiothreitol. Proteins were denatured in sodium dodecyl sulfate sample buffer, subjected to gel electrophoresis and transfer and blotted using rabbit antibodies against NT2-AnkG, NT3-AnkG and AnkG C-terminus.
Transfection and immunostaining
Human embryonic kidney (HEK) 293 cells were cultured, transfected and immunostained as described. 38 All immunostaining steps were performed in parallel for genotypes being compared. Initial experiments determining conditions and setting assumptions of statistical tests were performed using seven Ank3-1b KO/KO males, two Ank3-1b KO/+ females and four wildtype (WT) females. Final image collection for figures and quantification of results (except antibody validation shown in Supplementary Figure S2 ) was performed on male littermates: Ank3-1b KO/+ (n = 8) and WT (n = 17). Mice were deeply anesthetized using isofluorane and perfused with cold phosphate-buffered saline followed by 4% paraformaldehyde. Brains were postfixed (1.5 h at 25°C) and embedded in OCT (Tissue-Tek, Torrance, CA, USA). Cryosections (20 μm) were mounted on Superfrost Plus slides (Fisher, Waltham, MA, USA). Human and mouse section staining protocols and HEK cell epifluorescence/brightfield imaging was performed as described. 38 For dual labeling using PV and AnkG antibodies, conditions for fixation (sufficient to fix PV proteins in the tissue, but weak enough to preserve strong AnkG immunoreactivity) were optimized by transcardiac perfusion with 4% paraformaldehyde in phosphate-buffered saline and sampling at postfixation durations of 0.5, 1, 1.5 and 2 h, after which blocks were transferred to 30% sucrose overnight and embedded for later sectioning.
Confocal imaging and analysis
Images were collected using a Nikon C2 confocal microscope, 20 × dry and 60 × oil immersion planapo objectives, and NIS-Elements software (Nikon, Melville, NY, USA). Brain regions were identified using a mouse brain atlas. 39 For quantification experiments, slides were coded by one experimenter, and images were acquired and analyzed by another experimenter blinded to sample genotype. High-resolution image stacks (NA 1.4; xy interval = 0.06-0.09 μm; z interval = 0.238 μm; pinhole: 0.6-0.8 Airy unit) were acquired. The origin and distal tip of each AIS was carefully determined using maximal projection and 3D views (Supplementary Movie S1). Only neurons whose AISs were entirely contained within the imaged volume were included in measurements of AIS size and labeling intensity. Using NIS-Elements tools, AIS labeling quantification was performed in parallel by two alternative approaches: an intensity threshold/region of interest strategy, and a line sampling strategy described previously. 22 These yielded very similar results and region of interest measurements are reported here. Nested repeated-measures two-way analysis of variance (six AISs per mouse and four mice per genotype) was used to determine the significance of changes in PV interneuron-labeling intensities in WT compared with Ank3-1b KO/+ mice (Prism, GraphPad, La Jolla, CA, USA).
Video-electroencephalography
Video-EEG monitoring was performed as described previously, 37 at 6-8 weeks of age, over a single, continuous 24-h period for each animal. During manual video-EEG review, the frequency of spikes (40 ms, 600 μV), cumulative spike-wave (SW) time, SW event frequency and average event duration were measured. SW discharges were included in event calculations if they lasted ⩾ 500 ms, had voltage amplitudes ⩾ 2 × the interictal baseline and had frequencies of 5-9 Hz. Videos and simultaneous EEG were analyzed for corresponding behavioral changes. Group comparison statistical significance was tested using a nonparametric Mann-Whitney test (Prism).
Slice electrophysiology
Experiments were performed on Ank3-1b KO/KO and WT (n = 9 for each genotype, 4 males and 5 females) at 8-10 weeks of age. Recordings were made by an investigator blinded to genotype. Mice were deeply anesthetized using isoflurane and decapitated. The brains were immediately removed and transferred into ice-cold oxygenated slicing medium containing the following (in mM): 2.5 KCl, 1.25 NaH 2 PO 4 , 10 MgCl 2 , 0.5 CaCl 2 , 26 NaHCO 3 , 11 glucose, and 234 sucrose. Thalamocortical slices (300 μm) were cut using a vibratome by methods optimizing preservation of thalamocortical and intracortical connections, as described. 40, 41 Cut slices were rested in artificial cerebral spinal fluid (aCSF, in mM: 126 NaCl, 2.5 KCl, 1.25 NaH 2 PO 4 , 1.0 MgCl 2 , 2.0 CaCl 2 , 26 NaHCO 3 , and 10 glucose, gassed with 95% O 2 /5% CO 2 , pH 7.4) at 35°C for 1 h. Slice electrophysiology and synaptic conductance calculation was performed as described previously. 42 Initial analysis showed no sex differences, and in the results shown here, data for the two sexes are pooled.
Statistical procedures
Power analysis was performed using G*Power (University of Dusseldorf, Dusseldorf, Germany) using estimates of effect size based on preliminary experiments. All calculated means are expressed as ± s.e.m.
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RESULTS
Alternative N-termini define brain AnkG subfamilies To elucidate the potential distinctive neural functions of AnkG subtypes, we generated NT1, NT2 and NT3 isoform-specific antibodies using sequences derived from human exons 1a/1a', 1b and 1e (Supplementary Figure S1 ). Control western blotting and immunostaining using these antibodies demonstrated their specificity and utility (Supplementary Figure S2 ). In western blottings experiment against the mouse brain proteins, both NT2 and NT3 antibodies detected the canonical AnkG 480 and 270 and 190 kD polypeptides, consistent with previous mRNA studies in human and mouse. 20, 21, 43 NT1 antibodies detected heterologously expressed protein well (Supplementary Figures S2a and c) but showed no reactivity against mouse brain tissue and, in particular, no staining of AISs (discussed below, Supplementary  Figures S2i and S6d ). By contrast, affinity-purified NT2 and NT3 antibodies showed widespread, overlapping, non-identical mouse brain regional immunolabeling patterns that were completely absent in samples reacted with preimmune sera (Supplementary Figure S2f ). In the cerebellar cortex, NT3 strongly labeled stellate, basket, Purkinje and granule cell AISs; transgenic mice lacking the expression of NT3-AnkG exhibited complete loss of AnkG immunostaining from these cerebellar AISs. In cerebellar Golgi cells, AISs stained for NT2. No cerebellar AISs of WT or mutant mice were labeled by NT1 ( Supplementary  Figures S2g-j) . 20, 38 NT3-AnkG's role in the forebrain PV interneurons ANK3-exon1b mRNA is found in the forebrain, 21 but protein localization has not been previously shown. Staining with NT3-AnkG antibodies revealed widespread, regionally varied labeling ( Supplementary Figures S3a-d) . The frontal cortex, orbitofrontal cortex and anterior cingulate cortex showed especially strong labeling. Other areas of the limbic system, including the hippocampal dentate gyrus and amygdala, as well as the basal ganglia and the reticular thalamic nucleus, exhibited strong NT3-AnkG labeling. We systematically analyzed AnkG isoform expression in brain regions implicated in emotion processing in BD. 44 In the hippocampus, labeling for NT2-AnkG was more conspicuous than for NT3-AnkG (Figures 1c and e ). However, as in the cerebellum, higher resolution imaging revealed a striking, celltype-specific pattern. NT2 and NT3 antibodies both strongly labeled AISs of dentate granule cells (Figures 1d and f) . AISs of hippocampal pyramidal cells were strongly labeled by NT2-AnkG antibodies and lacked NT3-AnkG staining (Figures 1c, e and g-j) . However, a few AISs within and outside the pyramidal cell layer in all CA regions were strongly NT3 positive. Colabeling and 3D reconstruction, (Supplementary Movie S1) revealed that each CA region NT3-labeled AIS arose from a PV interneuron soma or proximal dendrite (n = 46, Figures 1g and h) and that all PV interneuron AISs were NT2 negative (n = 25, Figures 1i and j) . This unexpected result led us to collect high-resolution images of PV interneuron AISs in other forebrain regions implication in emotional control, including the amygdala (n = 27, Figure 2 ), the orbitofrontal cortex (n = 54, Supplementary Figure S4 ), and the anterior cingulate cortex (Figure 3c-f ). In these regions, all PV interneuron AISs were labeled only by NT3-AnkG. Principal cells and non-PV interneurons stained for NT2-AnkG and NT3-AnkG in ratios that varied between neighboring cells within a circuit (Figures 3d, h, Supplementary Figures S4c and f) . A striking exception to this pattern was found in the caudoputamen, where the medium spiny neurons, similar to hippocampal pyramidal cells, all labeled exclusively for NT2-AnkG (Supplementary Figure S5 ).
In mice, homozygous deletion of exon 1b (Ank3-1b KO/KO ) results in a complete loss of AnkG, Na V channels and KCNQ2/3 channels at most cerebellar cortex AISs, including basket and stellate cells that are PV interneurons ( Supplementary Figures S2e-g) . 20, 38 Consistent with that, in Ank3-1b KO/KO mice, forebrain PV interneuron AISs were not detectable by AnkG or PanNa V antibodies (data not shown). In heterozygous Ank3-1b KO/+ mice, labeling for PanAnkG, NT3-AnkG and PanNa V was reduced by approximately half (Figures 1k and l) . Reduced AIS length (Supplementary Figure S6b ) and reduced labeling density both contribute to the overall reduction in total AnkG and PanNa V labeling at PV cell AISs of Ank3-1b KO/+ mice. PanAnkG and PanNa V labeling of CA1 pyramidal neuron AISs was unchanged ( Supplementary  Figure S6a ). NT1 and NT2 remained undetectable at Ank3-1b KO/+ mouse CA1 PV interneuron AISs (n = 18; Supplementary Figures  S6c and d) . Thus reduced NT3 levels produce no effective compensatory expression of NT1 or NT2 isoforms in these cells.
NT3-AnkG in mouse and human neocortex
To begin to compare ankyrin labeling in mouse and human brain, we focused on frontal or temporal cortex, as samples from these regions removed as part of neurosurgical care at our center could be immediately processed in parallel with mouse samples. In all layers of the mouse frontal cortex, pyramidal cell AISs are labeled for NT2 and NT3 (Figures 3a and b ). Mouse frontal cortical PV interneuron AISs all stained strongly for NT3-AnkG (n = 24) and undetectably for NT2-AnkG (n = 19; Figures 3c and e). Cingulate cortex pyramidal cell AISs were heterogeneous in their NT2 and NT3 labeling strength (Figures 3d and f) . In the orbitofrontal cortex as well, PV interneuron AISs labeled robustly for NT3-AnkG (n = 5) and lacked NT2-AnkG (n = 6; Supplementary Figures S4a, b, d and  e ), but pyramidal cells showed heterogeneity of NT2-and NT3-AnkG staining ( Supplementary Figures S4c and f) . In human frontal cortex, AnkG isoform expression exhibited the same neuronal cell-type-dependent pattern: PV interneuron AISs stain strongly for NT3-AnkG (Figure 3g, n = 15 ) and lack NT2-AnkG ( Figure 3j, n = 15 ), and pyramidal cell AISs included subgroups labeled by NT2-and NT3-AnkG isoforms in widely varying ratios (Figures 3h, i, k and l) . Immunostaining of human neocortical sections using NT1 antibodies revealed no staining of either pyramidal cell or PV interneuron AISs or somata (Supplementary Figure S6e ).
Reduced inhibition in Ank3-1b mutant mice Forebrain PV interneurons hypofunction is implicated in epilepsy, many Mendelian neurodevelopmental disorders, and psychiatric illness, including BD and schizophrenia. [45] [46] [47] [48] In mice, heterozygous deletion of Ank3 exon 1b has been shown to lead to deficient expression of all AnkG isoforms containing NT3 20,21,43 and a behavioral phenotype modeling both mania and depression, 31 but the mechanisms for this are not clear. Given the exclusive reliance of PV interneurons on Ank3 exon 1b isoforms, we analyzed the effects of deficient Ank3-1b expression in interneurons, at the behavioral, neuronal network and cellular levels. Video-EEG telemetry of Ank3-1b KO/+ -PVtom and Ank3-1b KO/KO -PVtom mice revealed frequent episodes of generalized 6-7 Hz SW seizures (Figure 4a ). Mice exhibited clear behavior arrest at SW onset and resumption of normal behavior immediately following SW offset (Supplementary Movie S2). Ank3-1b KO/KO -PVtom mice also experienced rare unprovoked convulsions and unexplained sudden death not seen in either WT mice or the heterozygous Ank3 mutants (Figure 4b) . In Ank3-1b KO/KO -PVtom mice, repetitive SW discharges of at least 0.5 s duration occupied 3.9% of the total EEG time; in Ank3-1b KO/+ -PVtom mice, these discharges occurred much less frequently (Figure 4c ). Mice lacking AnkG specifically in PV interneurons, generated by crossing Flox-Ank3 36 and PV-cre lines, showed the same dose-dependent epilepsy phenotype seen in the Ank3-1b mutant mice (Figure 4c ), providing robust intersectional genetic evidence that the epilepsy was due to loss of NT3-AnkG in PV interneurons. Thalamocortical interactions are implicated in SW epilepsy, and PV interneuron AISs of the thalamic reticular nucleus labeled strongly for NT3-AnkG and not for NT2-AnkG (Supplementary Figure S7) .
Loss of Na V channels at PV interneuron AISs may cause such excitation/inhibition imbalance and epilepsy by diminishing inhibition selectively. 49 To assess this, we measured excitatory and inhibitory conductances in the somatosensory barrel cortex under whole-cell voltage clamp. [50] [51] [52] [53] Using a bipolar field electrode placed just below the recorded barrel, we adjusted stimulation intensity to induce a small inhibitory synaptic response in whole-cell patched layer IV spiny stellate cells at 0 mV. This likely is due to effects on parvalbumin (PV) neurons, as Flox-Ank3 KO/KO also have more discharges per hour (P = 0.0266) and experience more SW activity than Flox-Ank3 KO/+ (P = 0.0266). (d) Top, evoked synaptic current under different holding potentials (−60, − 40, − 10 mV). Bottom, the compound synaptic conductance G syn , excitatory conductance G e and inhibitory conductance, G i . The G e /G i ratio is significantly higher in Ank3-1b KO/KO -PVtom mice (0.39 ± 0.2, n = 7) compared with control (0.2 ± 0.1, n = 9, P = 0.02), owing to decreased G i in KO (2.05 ± 1.4, n = 9) compared with control (3.9 ± 2.9, n = 7, P = 0.04).
We then recorded synaptic currents at − 60, − 40 and − 10 mV and calculated the underlying excitatory and inhibitory conductances.
The G e /G i ratio was significantly elevated in the Ank3-1b KO/KO -PVtom compared with Ank3-1b +/+ -PVtom mice, owing to decrease in G i but not G e (Figure 4d ).
Ank3-1b KO/KO PV interneurons have diminished excitability
Reduced inhibitory conductance could reflect impaired function at the inhibitory synapse or loss of interneuron intrinsic excitability. Paradoxically, when we recorded spontaneous inhibitory postsynaptic currents from layer IV somatosensory spiny stellate cell, we found that mean amplitude was somewhat increased in the mutant mice, and frequency was unchanged ( Supplementary  Figures S8a-c) . Spontaneous excitatory postsynaptic currents were unchanged in Ank3-1b KO/KO mice (Supplementary Figure S8d) . Thus the reduced inhibitory conductance we observed does not appear to be due to deficiency of synaptic transmission. By contrast, the threshold extracellular field stimulus strength required to evoke spikes in PV neurons was markedly higher in Ank3-1b KO/KO -PVtom mice than in littermate controls (Figure 5a ). Maximal responses were significantly reduced, and the stimulusresponse curve was shifted to the right across all the intensities tested (Figures 5b and c) . Experiments using direct current injections revealed unchanged passive properties but further evidence of markedly diminished PV interneuron excitability. Input resistance (61.5 ± 6.4 MΩ, n = 8 for Ank3-1b +/+ and 61.9 ± 3.6 MΩ, n = 7 for Ank3-1b KO/KO ) and resting membrane potential (−64.33 ± 2.6 mV, n = 8 for Ank3-1b +/+ and − 66.6 ± 2.1 mV, n = 7 for Ank3-1b KO/KO ) were similar in the two genotypes. However, the mean threshold current for inducing first spikes increased 94% in the mutant mice (264 ± 45.7 pA in Ank3-1b KO/KO -PVtom, and 136 ± 20 pA in controls, Figure 5f , Supplementary Figures S9a and b) . The AP voltage threshold was depolarized and its half-height duration was lengthened (Figures 5h and i) , and the ability to fire repetitively was diminished ( Supplementary Figures S9a-c) . Steady-state membrane potential change induced by different current injection intensities did not differ significantly in Ank3-1b KO/KO compared with Ank3-1b +/+ (Supplementary Figure S9e) . Although first spike amplitudes were not significantly smaller in Ank3-1b KO/KO compared with controls, latencies were longer (Supplementary Figures  S9f and g) . Reflecting these changes, AP phase plots from mutant mice exhibit clear changes in threshold, ascent and repolarization (Figure 5g ). In combination, extracellular stimulation and direct current injection experiments show that PV cell excitability in Ank3-1b KO/KO -PVtom mice is profoundly reorganized and very markedly reduced.
DISCUSSION
Several independent genome-wide association studies (GWASs) have implicated variation near the 5′ non-coding region of ANK3 in BD, [14] [15] [16] [17] [18] [19] but the underlying biological mechanisms are challenging to analyze and have been obscure. Taken together, the results shown here provide a compelling new explanation. We find that forebrain AnkG proteins include two major isoform families, defined by alternative promoters, first exons and N-termini, which make largely opposing contributions to neuronal circuit excitability. Inhibitory PV neurons rely exclusively on NT3 isoforms, whereas excitatory principal cells express either NT2 exclusively or combinations of NT2 and NT3. This previously unappreciated subdivision of AnkG function is important, as PV interneurons have critical roles in brain microcircuits, including feedforward and feedback inhibition, gamma oscillations and control of the slope (or gain) of input/output relationships. [33] [34] [35] Given the role of NT3-AnkG in PV cells, we studied heterozygous NT3-AnkG KO mice previously shown to exhibit behavioral abnormalities modeling mania and depression 21 and mice homozygous for the same deletion. The mice have epilepsy with gene-dosage-related severity. The homozygotes have very frequent seizures and sudden death. These phenotypes reflect deficient expression in PV interneurons; as they also could be produced by targeted deletion of Ank3 from PV neurons using Cre-lox. Hippocampal PV interneurons deficient in NT3-AnkG have a proportional loss in Na V channels at the AIS. We found that the CA1 PV AIS was approximately 25 μm long. The AIS distal tip determined by Na V and AnkG immunolabeling corresponds closely to the site of AP initiation mapped electrophysiologically. 23 Our staining and recording results show that NT3-AnkG null neocortical PV cells lack the requisite AIS channels and associated protein complexes, leading to dramatically impaired intrinsic excitability. This is manifested by increased synaptic stimulation and current injection required for firing, increased first latencies, depolarized AP thresholds, reduced firing rates, lengthened AP duration and a loss in AP height with sustained firing.
The severe early-onset circuit disorder exhibited by global, constitutive homozygous NT3-AnkG KO mice and PV neuronspecific AnkG-deleted mice represents one extreme along a spectrum of brain NT2/NT3 balance. Indeed a recent study identified three siblings with epilepsy and severe neurodevelopmental impairment owing to homozygous truncating ANK3 mutation. 54 Our results suggest that the modest effects of ANK3 variation observed in BD GWASs could arise from more subtle imbalances of AnkG isoform expression, or imbalances restricted in brain region or developmental stage. Recent human mRNA analyses have correlated reduced expression of NT3 isoforms with increased risk of BD, 21 and reduced NT2 isoform expression in adolescence and early adulthood with protection from BD and schizophrenia. 32 More comprehensive analysis of human mRNA and protein levels and parallel study in animals using behavioral paradigms modulating gene expression and protein function (for example, stress) are next steps for elucidating AnkG-related interneuronopathy.
One recent study screened individuals diagnosed with BD and controls for rare de novo variants in the ANK3 variably splice large exon, which lies downstream from another non-coding BD-associated single-nucleotide polymorphism (Figure 1a ). 55 Rare variants within conserved coding 32 and non-coding regions controlling NT3 and NT2 expression represent an appealing candidate mechanism for BD and epilepsy. Existing databases of genotyped BD patients from previous collaborative GWAS should be interrogated to learn whether epilepsy is more common in individuals bearing ANK3 single-nucleotide polymorphisms known to confer associated with increased BD risk. The GWAS approach has been less extensively exploited in epilepsy than in psychiatric disorders, and it will be interesting to learn whether future epilepsy GWASs implicate ANK3. 56 A full view of how the expression ratios of AnkG isoforms and their channel ligands [22] [23] [24] [25] are altered in BD and epilepsy promises to reveal specific new candidate therapeutic targets. Current thinking about mood disorders and epilepsy is often segregated into psychiatric and neurological perspectives, and the mechanisms underlying comorbidity between these diseases have not been adequately explored. Our work provides an example how unbiased human genetic studies can illuminate unforeseen connections between disease categories.
